YS Biopharma Co., Ltd. announced that it has entered into a share purchase agreement with an institutional investor to issue 95,269,762 ordinary shares at an issue price of $0.41986 per Share for the gross proceeds of $39,999,962.27332 on February 9, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6977 USD | +0.93% |
|
-8.20% | +36.54% |
Jun. 10 | Lakeshore Biopharma Co., Ltd Announces Executive Changes | CI |
May. 28 | YS Biopharma Co., Ltd. will Change its Ticker to LSB from YS | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.54% | 131M | |
+0.75% | 92.38B | |
-3.03% | 37.9B | |
-10.46% | 33.73B | |
+73.70% | 27.98B | |
-13.39% | 15.86B | |
-1.08% | 13.97B | |
-11.15% | 11.67B | |
+169.04% | 10.17B | |
-50.19% | 10.04B |
- Stock Market
- Equities
- LSB Stock
- News LakeShore Biopharma Co., Ltd
- YS Biopharma Co., Ltd. announced that it expects to receive $39.999962 million in funding